About: Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
Creator	Smith, Martin Davies, Nicholas Pollak, Thomas Thomas, Rhys Michael, B Thomas, R Benjamin, L Coles, Jonathan Easton, Ava Ellul, Mark Manji, Hadi Michael, Benedict Nicholson, Laura Phd, Easton Thomas, Naomi Varatharaj, Aravinthan Zandi, Michael Breen, Gerome Al-Shahi, Rustam Benjamin, Alan Carson, Craig Ellul, M Galea, Kneen, R Kneen, Sarah Menon, Timothy Mrcp, Ellul Mrcpch, Thomas Pett, Ian Phd, Michael Salman, David Solomon, Rachel Solomon, T Sultan, M Sultan, Mustafa Tenorio, Elizabeth Turner, Tom
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Concerns regarding potential neurological complications of COVID-19 are being increasingly reported, primarily in small series. Larger studies have been limited by both geography and specialty. Comprehensive characterisation of clinical syndromes is crucial to allow rational selection and evaluation of potential therapies. The aim of this study was to investigate the breadth of complications of COVID-19 across the UK that affected the brain. METHODS: During the exponential phase of the pandemic, we developed an online network of secure rapid-response case report notification portals across the spectrum of major UK neuroscience bodies, comprising the Association of British Neurologists (ABN), the British Association of Stroke Physicians (BASP), and the Royal College of Psychiatrists (RCPsych), and representing neurology, stroke, psychiatry, and intensive care. Broad clinical syndromes associated with COVID-19 were classified as a cerebrovascular event (defined as an acute ischaemic, haemorrhagic, or thrombotic vascular event involving the brain parenchyma or subarachnoid space), altered mental status (defined as an acute alteration in personality, behaviour, cognition, or consciousness), peripheral neurology (defined as involving nerve roots, peripheral nerves, neuromuscular junction, or muscle), or other (with free text boxes for those not meeting these syndromic presentations). Physicians were encouraged to report cases prospectively and we permitted recent cases to be notified retrospectively when assigned a confirmed date of admission or initial clinical assessment, allowing identification of cases that occurred before notification portals were available. Data collected were compared with the geographical, demographic, and temporal presentation of overall cases of COVID-19 as reported by UK Government public health bodies. FINDINGS: The ABN portal was launched on April 2, 2020, the BASP portal on April 3, 2020, and the RCPsych portal on April 21, 2020. Data lock for this report was on April 26, 2020. During this period, the platforms received notification of 153 unique cases that met the clinical case definitions by clinicians in the UK, with an exponential growth in reported cases that was similar to overall COVID-19 data from UK Government public health bodies. Median patient age was 71 years (range 23–94; IQR 58–79). Complete clinical datasets were available for 125 (82%) of 153 patients. 77 (62%) of 125 patients presented with a cerebrovascular event, of whom 57 (74%) had an ischaemic stroke, nine (12%) an intracerebral haemorrhage, and one (1%) CNS vasculitis. 39 (31%) of 125 patients presented with altered mental status, comprising nine (23%) patients with unspecified encephalopathy and seven (18%) patients with encephalitis. The remaining 23 (59%) patients with altered mental status fulfilled the clinical case definitions for psychiatric diagnoses as classified by the notifying psychiatrist or neuropsychiatrist, and 21 (92%) of these were new diagnoses. Ten (43%) of 23 patients with neuropsychiatric disorders had new-onset psychosis, six (26%) had a neurocognitive (dementia-like) syndrome, and four (17%) had an affective disorder. 18 (49%) of 37 patients with altered mental status were younger than 60 years and 19 (51%) were older than 60 years, whereas 13 (18%) of 74 patients with cerebrovascular events were younger than 60 years versus 61 (82%) patients older than 60 years. INTERPRETATION: To our knowledge, this is the first nationwide, cross-specialty surveillance study of acute neurological and psychiatric complications of COVID-19. Altered mental status was the second most common presentation, comprising encephalopathy or encephalitis and primary psychiatric diagnoses, often occurring in younger patients. This study provides valuable and timely data that are urgently needed by clinicians, researchers, and funders to inform immediate steps in COVID-19 neuroscience research and health policy. FUNDING: None.
has issue date	2020-06-25(xsd:dateTime)
bibo:doi	10.1016/s2215-0366(20)30287-x
bibo:pmid	32593341
has license	no-cc
sha1sum (hex)	3ba4f93c24ed5b0c2274e947d1ba90f09d228ccd
schema:url	https://doi.org/10.1016/s2215-0366%2820%2930287-x
resource representing a document's title	Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
has PubMed Central identifier	PMC7316461
has PubMed identifier	32593341
schema:publication	Lancet Psychiatry
resource representing a document's body	covid:3ba4f93c24ed5b0c2274e947d1ba90f09d228ccd#body_text
is schema:about of	named entity 'geography' named entity 'ACROSS' named entity 'COVID-19' named entity 'SELECTION' named entity 'THERAPIES' named entity 'rational' named entity 'Comprehensive' named entity 'Larger' named entity 'complications' named entity 'neuropsychiatric' named entity 'Neurological' named entity 'altered mental status' named entity 'vascular events' named entity 'nerve roots' named entity 'influenza' named entity 'China' named entity 'encephalitis' named entity 'socioeconomic' named entity 'neurology' named entity 'Wuhan' named entity 'ischaemic' named entity 'dizziness' named entity 'cerebrovascular event' named entity 'COVID19' named entity 'UK Government' named entity 'altered mental status' named entity 'MRC' named entity 'relative risk' named entity 'cerebrovascular events' named entity 'neurotropism' named entity 'psychiatric diagnoses' named entity 'exponential phase' named entity 'data sharing' named entity 'neuropsychiatric' named entity 'health policy' named entity 'MRI' named entity 'altered mental status' named entity 'Wellcome' named entity 'cerebrovascular events' named entity 'stroke' named entity 'neurology' named entity 'stroke' named entity 'encephalitis' named entity 'muscle' named entity 'neuropsychiatric'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software